Clinical study of polycystic ovarian syndrome (PCOS) in tertiary care centre

Sowmya D., Anitha S.


Background: A true definition of polycystic ovarian syndrome involves a blending of the morphological and histological ovarian changes with endocrine abnormalities associated with these changes. Objective of present study was to detect the differences among women with PCOS and without PCOS.

Methods: Twenty-five subjects with PCOS were included in the study on first cum first basis and twenty-five non PCOS subjects just next to each PCOS cases were included as control group.

Results: Mean age of PCOS and Non PCOS subjects were 42.68 and 43.88 years respectively. Sixteen percentage of PCOS were from higher socio-economic status, which was statistically significant. PCOS subjects had 96% hirsuitism, 48% acne, 4% heavy voice and breast atropy which was also statistically significant.

Conclusions: Women with PCOS have a hormonal imbalance and metabolism problems that may affect their health and fertility, we found PCOS subjects are more in urban population with strong family history. Lifestyle modification and dietary modification helps for the long-term health prognosis. women who are at risk of PCOS to be educated and managed for the continuing health risk and planned potential therapeutic strategies. Further research has to look into possibility of genes linked into PCOS.


Hormonal imbalance, PCOS, Non PCOS

Full Text:



Adam HB, Joop SE, Seang-Lin T, Dewailly D. Ultrasound assessment of the polycystic ovary : international consensus definitions. Human Reprod Update. 2003;9:505-14.

Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic syndrome: the ovarian stroma / total area ratio. Fertil Steril. 2001;76:326-31.

Marantides D. Management of polycystic ovary syndrome. Nurse Pract. 1997;22(12):34-38.

Takahashi K, Eda Y, Abu Musa A, Okada S, Yoshino K, Kitao M. Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome. Human Reprod.1994;9:1231-6.

Abdel Gadir A, Khatim MS, Mowafi RS, Alnasser HM, Muharib NS, Shaw RW. Implications of ultrasonically diagnosed polycystic ovaries. Its corrections with basal hormonal profiles. Human Reprod. 1992;7(4):453-7.

Rumack CM, Wilson BR, Charbonean JW. Diagnostic ultrasound. 3rd ed. Missouri: Elsevier Mosby; 2005:561-2.

Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clinical Endocrinol. 2004;60:1-17.

Fritz MA, Speroff L. Clinical Gynaecologic Endocrinology and Infertility. Chronic Anovulation and The Polycystic Ovarian Syndrome. 8th ed. Lippincot: William and Wilkins;2012:475-531.

Brown DL, Henrichsen TL, Clayton AC, Hudson S, Coddington CC, Vella A. Ovarian stromal hyperthecosis. J Ultrasound Med. 2009;28:587-93.

Nardo LG, Buckett WM, White D, Digesu AG, Franks S, Khullar V. Three dimensional assessment of ultrasound features in women with Clomiphene citrate-resistant polycystic ovarian syndrome (PCOS): ovarian stromal volume does not correlate with biochemical indices. Human Reprod. 2002;17:1052-5.

Berek JS, Berek DL. Berek and Novak's Gynecology. Endocrinological Disorders. 8th ed. Lippincot: William and Wilkins;2013:1075-94.

Mukherjee GG, Chakravarty BN. Polycystic ovary syndrome: an update. Imaging of the Polycstic Ovary. 1st ed. Jaypee Brothers;2013:30-36.

Adams J, Polson DW, Abdul Wahid N, Morris DV, Frank S, Mnson HD et al. Multifollicular Ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet. 1985;2:1375-9.

Choi JH, Gilks CB, Auersperg N, Leung PC. Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary. J Clin Endocrinol Metabol. 2006;91(11):4562-70.

San‐Millán JL, Escobar‐Morreale HF. The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence. Clin Endocrinol. 2010;72(3):383-92.

Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, McAllister JM, Mosselman S, Strauss JF. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem. 2003;278(29):26380-90.

Marx TL, Mehta AE. Polycystic ovary syndrome: pathogenesis and treatment over the short and long term. Cleve Clin J Med. 2003;70(1):31-3, 36-41, 45.

Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med. 1995;98(suppl 1A):33S-39S.

Garruti G, de Palo R, Rotelli MT, Nocera S, Totaro I, Nardelli C, Panzarino MA et al. Association between follicular fluid leptin and serum insulin levels in nonoverweight women with polycystic ovary syndrome. BioMed Res Int. 2014;2014:980429.

Tock L, Carneiro G, Pereira AZ, Tufik S, Zanella MT. Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome. Int J Endocrinol. 2014;2014:620605.